- Janice Hopkins Tanne
- 1New York
Merck listed $3.7m in payments to US medical experts for speaking on behalf of the company or its products between 1 July and 30 September of this year. It followed Eli Lilly in disclosing payments to doctors who speak for companies.
Pfizer and GlaxoSmithKline have promised to make similar disclosures, according to the Associated Press news agency (www.ap.org, 19 Oct 2009, “Merck starts revealing payments to doctor-speakers”).
The list on Merck’s website discloses payments to 1078 doctors and other experts who took part in Merck speaking engagements during July-September. The list includes the names …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Ventilator associated pneumonia
Published 30 May 2012
Re: Restless legs syndrome
Published 30 May 2012
Author's reply
Published 30 May 2012
Re: Full access to trial data holds many benefits and a few pitfalls, conference hears
Published 30 May 2012
Restless Legs Syndrome: Fact or Fiction
Published 30 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27